Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma

Clinical trial NCT06319196 · RECRUITING

Trial details

NCT number: NCT06319196
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Melanoma Melanoma Stage IV Mucosal Melanoma

Start date: 2026-08-27
Primary completion: 2027-02-15
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.